Caredx to report third quarter 2025 financial results on november 4, 2025

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the third quarter 2025 after market close on tuesday, november 4, 2025. the company will host a webcast and conference call that day at 1:30 p.m. pt / 4:30 p.m. et. a live and archived webcast.
CDNA Ratings Summary
CDNA Quant Ranking